Found: 4 articles
Article | Edition |
---|---|
N.S. Besova, T.A. Titova, A.A. Tryakin, E.V. Artamonova, D.L. Stroyakovsky, E.V. Perminova, D.Yu. Yukalchuk, D.M. Ponomarenko, N.P. Belyak, R.V. Orlova, G.M. Teletaeva, E.Yu. Ratner, A.S. Mochalova, A.S. Zhabina, S.V. Gamayunov, A.V. Smolin, A.Yu. Povyshev, M.I. Andrievskikh, I.S. Stilidi
Efficacy of ramucirumab in the second-line treatment of patients with disseminated gastric cancer in routine clinical practice in Russia (RAMSELGA observational study)
|
№7 / 2024 |
N.P. Belyak (1, 2), S.I. Kutukova (1, 3), R.V. Orlova (1, 2), N.V. Zhukova (1, 2), S.P. Erdniev (1), E.Yu. Zorina (1), I.V. Avramenko (1), N.Yu. Antimonik (1), N.V. Popova (1), A.K. Ivanova (1), A.V. Androsova (1)
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
|
№7 / 2019 |
T.A. Titova, N.S. Besova, V.A. Gorbunova, A.A. Fedenko, O.A. Malikhova
RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT
|
№7 / 2018 |
A.I. Semenova, S.A. Protsenko, A.V. Novik, D.H. Latipova, G.M. Teletayeva, T.Y. Semiglazova
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
|
№17 / 2016 |